Find the Perfect Plan for Your Investment Journey
S
Latest price
52 Week Range
€139.10 - €239.80
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | €19.59B |
EV | €21.85B |
Shares Outstanding | 97.30M |
Beta | 0.98 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | €252.50 |
P/E 2025E | 46.18x |
P/Revenue 2025E | 6.52x |
Revenue | -1.30% |
EPS | -22.40% |
Operating Cash Flow | 5.40% |
Free Cash Flow | 8.50% |
Revenue | 10.40% |
EPS | 24.90% |
Operating Cash Flow | 6.50% |
Free Cash Flow | -2.20% |
Gross Margin 2025E | 46.47% |
Net Profit Margin 2025E | 10.99% |
ROE 2025E | 10.08% |
ROCE 2024 | 5.29% |
DPS 2025E | €0.74 |
Payout Ratio 2025E | 16.97% |
Div. Yield 2025E | 0.37% |
DPS Last 3Y CAGR | -18.20% |
Price
%
1M
3M
6M
1Y
3Y
5Y
S
Sartorius Stedim Biotech S.A.
DIM
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Faber, Rene
Employees
9,961
Website
www.sartorius.comIPO Date
2000-01-03
Headquarters
Zone Industrielle Les Paluds, Avenue de Jouques – CS 91051, Cedex, Aubagne, Provence-Alpes-Côte d'Azur, 13781, France
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved